Detalles de la búsqueda
1.
Three Dose Levels of a Maternal Respiratory Syncytial Virus Vaccine Candidate Are Well Tolerated and Immunogenic in a Randomized Trial in Nonpregnant Women.
J Infect Dis
; 225(12): 2067-2076, 2022 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34146100
2.
First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector-Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults.
Clin Infect Dis
; 70(10): 2073-2081, 2020 05 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31340042
3.
Immunogenicity and Safety of 3 Formulations of a Respiratory Syncytial Virus Candidate Vaccine in Nonpregnant Women: A Phase 2, Randomized Trial.
J Infect Dis
; 220(11): 1816-1825, 2019 10 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31418022
4.
Safety and Immunogenicity of 3 Formulations of an Investigational Respiratory Syncytial Virus Vaccine in Nonpregnant Women: Results From 2 Phase 2 Trials.
J Infect Dis
; 217(10): 1616-1625, 2018 04 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-29401325
5.
Hamster neogenin, a host-cell protein contained in a respiratory syncytial virus candidate vaccine, induces antibody responses in rabbits but not in clinical trial participants.
Hum Vaccin Immunother
; 16(6): 1327-1337, 2020 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31951765
Resultados
1 -
5
de 5
1
Próxima >
>>